We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BiomX

News List

BiomX collaborates with Boehringer Ingelheim for microbiome-based biomarkers for IBD expresspharma
September 03, 2020
The terms of the collaboration also include an option for Boehringer Ingelheim to negotiate an exclusive right to biomarkers discovered utilising the XMarker platform.
BiomX Completes In-house Phage Manufacturing Facility contractpharma
September 04, 2019
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, has completed construction of a new state-of-the-art manufacturing facility.
BiomX raises funds to advance drug candidates for acne and IBD pharmaceutical-technology
February 22, 2019
Israeli drug discovery firm BiomX has raised funds in a series B round to advance its lead acne and inflammatory bowel disease (IBD) drug programmes to the clinic.....
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD pharmafocusasia
December 13, 2018
BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has entered into a collaboration with Janssen Research & Development...
BiomX in-licenses novel bacterial targets for IBD treatment biospectrumasia
February 01, 2018
BX002 offers a groundbreaking approach for treating IBD as it targets a possible underlying cause for the disease